Karyopharm Therapeutics
KPTI
#8602
Rank
S$0.13 B
Marketcap
$1.08
Share price
14.66%
Change (1 day)
-35.13%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$1.78

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.72. In 2022 the company made an earnings per share (EPS) of -$2.64 a decrease over its 2021 EPS that were of -$2.16.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.78-32.78%
2022-$2.6422.29%
2021-$2.16-39.19%
2020-$3.56-15.48%
2019-$4.213.19%
2018-$4.0811.79%
2017-$3.65-4.44%
2016-$3.82-11.75%
2015-$4.3237.76%
2014-$3.14-74.5%
2013-$12.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.37-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.17-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.87-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.37-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA